Empagliflozin ameliorates ventricular arrhythmias by inhibiting sympathetic remodeling via nerve growth factor/tyrosine kinase receptor A pathway inhibition.
| Autor: | Yuling Jing, Yanling Ding, Hengsong Fu, Tao Li, Ting Long, Qiang Ye |
|---|---|
| Zdroj: | Journal of Cardiovascular Medicine; Sep2024, Vol. 25 Issue 9, p664-673, 10p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|